| Revenue Growth | Total revenue up 12.2%; ventilator rentals $37.5M, up 7.4% year-over-year. |
|---|---|
| Mgmt Confidence | High confidence in 4Q seasonality and maternal health rollout success. |
| Demand Visibility | Sleep therapy patients up 37.5%; resupply patients up 22% year-over-year. |
| Margin Trends | Adjusted EBITDA margin 21.1%, expanded 350 basis points sequentially from 2Q. |
| Op. Leverage | Revenue grew faster than SG&A; focus on volume through existing systems. |
| Vol vs Price | Growth driven by volume; 43,861 PAP patients, up 6,000 sequentially. |
| Segment Growth | Equipment and supply sales grew 23.7% supported by sleep and women's health. |
| New Clients | Added new distribution partner; expanding referral relationships in maternal health markets. |
| Capex & Debt | Lowered net capex outlook to 8-9% of revenue; repaid $2.1M debt. |
| Regulatory | Increased audit activity across industry; management advocating for reduced provider burden. |
| Commentary | Strategic shift toward less capital-intensive sales and services to drive free cash. |
| New Launches | Entering two additional states per quarter for maternal health starting 4Q. |
Growth
Revenue grew 12.2% year-over-year to $80.7 million; net income rose 32% to $4.6 million.
Outlook
Raised full-year revenue guidance to $316M-$320M; targeting two-state maternal health expansion cadence per quarter.
Risks
Audit-related payment timing and system migrations increased accounts receivable, temporarily tying up working capital.
The company's earnings call, NASDAQ: VMD, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Viemed Healthcare, Inc.: key numbers
- Share price
- $9.15Close, Nov 16
- Market cap
- $347M
- Shares outstanding
- 37.89MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Misc Health & Allied Services, NECSIC 8090
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Viemed Healthcare, Inc.
All →Viemed Healthcare Q3 2026 Results: Net Income $4.64M, Up 32.0% YoY
Viemed Healthcare reported a 20.7% increase in revenue for the nine months ended September 30, 2026, reaching $234.2 million compared to $194.1 million in the prior year. Net income attributable to the company grew to $10.0 million for the same period, while the company maintained a strong balance sheet with $150.1 million in total shareholders' equity.
- Key figure
- Net income $4.64M · +32.0% YoY
Viemed Healthcare Financial Results
Viemed Healthcare reported record third-quarter 2026 net revenue of $80.7 million, a 12.2% year-over-year increase driven by growth in ventilator and PAP therapy patient volumes. The company raised the low end of its full-year 2026 revenue guidance to a range of $316 million to $320 million and improved its net capital expenditure outlook.
- Term
- Q3 2026
“Viemed delivered another record quarter, with revenue reaching $80.7 million and continued growth across our respiratory, sleep, and women's health businesses.”
Casey Hoyt, Viemed’s CEO